Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal cone cell | 3 studies | 34% ± 2% | |
retinal rod cell | 3 studies | 29% ± 10% |
Insufficient scRNA-seq data for expression of CELF6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2147.22 | 89 / 89 | 0% | 0.00 | 1 / 901 |
bladder | 100% | 1155.67 | 21 / 21 | 0% | 0 | 0 / 504 |
ovary | 100% | 2755.90 | 180 / 180 | 0% | 0 | 0 / 430 |
prostate | 100% | 1588.64 | 245 / 245 | 0% | 0 | 0 / 502 |
thymus | 100% | 3302.62 | 653 / 653 | 0% | 0 | 0 / 605 |
breast | 100% | 1051.69 | 457 / 459 | 0% | 0 | 0 / 1118 |
intestine | 99% | 1401.65 | 958 / 966 | 0% | 0 | 0 / 527 |
spleen | 99% | 1216.35 | 239 / 241 | 0% | 0 | 0 / 0 |
lung | 99% | 1109.42 | 572 / 578 | 0% | 0 | 0 / 1155 |
brain | 98% | 2045.00 | 2602 / 2642 | 0% | 0 | 0 / 705 |
adipose | 98% | 1056.76 | 1183 / 1204 | 0% | 0 | 0 / 0 |
uterus | 98% | 2044.14 | 167 / 170 | 0% | 0 | 0 / 459 |
adrenal gland | 98% | 912.33 | 252 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 95% | 798.58 | 1262 / 1335 | 0% | 0 | 0 / 0 |
heart | 80% | 478.48 | 693 / 861 | 0% | 0 | 0 / 0 |
esophagus | 77% | 901.20 | 1107 / 1445 | 0% | 0 | 0 / 183 |
stomach | 70% | 514.72 | 252 / 359 | 0% | 0 | 0 / 286 |
pancreas | 67% | 356.41 | 219 / 328 | 0% | 0 | 0 / 178 |
liver | 62% | 316.19 | 139 / 226 | 0% | 0 | 0 / 406 |
skin | 56% | 307.79 | 1018 / 1809 | 0% | 0 | 0 / 472 |
peripheral blood | 19% | 82.59 | 178 / 929 | 0% | 0 | 0 / 0 |
muscle | 17% | 82.50 | 140 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CELF6 |
Protein name | CUGBP Elav-like family member 6 (CELF-6) (Bruno-like protein 6) (CUG-BP- and ETR-3-like factor 6) (RNA-binding protein BRUNOL-6) CUGBP Elav-like family member 6 |
Synonyms | BRUNOL6 |
Description | FUNCTION: RNA-binding protein implicated in the regulation of pre-mRNA alternative splicing. Mediates exon inclusion and/or exclusion in pre-mRNA that are subject to tissue-specific and developmentally regulated alternative splicing. Specifically activates exon 5 inclusion of TNNT2 in a muscle-specific splicing enhancer (MSE)-dependent manner. Promotes also exon exclusion of INSR pre-mRNA. . |
Accessions | ENST00000567083.2 [Q96J87-3] F6UBL3 ENST00000543764.6 [Q96J87-4] ENST00000395258.7 [Q96J87-2] ENST00000437872.7 Q96J87 ENST00000287202.10 [Q96J87-1] |